Detalhe da pesquisa
1.
Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia.
BMC Nephrol;
17(1): 97, 2016 07 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27460779
2.
Challenges, considerations, and approaches for developing a cost-effectiveness model for the adjuvant treatment of muscle-invasive urothelial carcinoma: with a spotlight on nivolumab versus placebo.
J Med Econ;
27(1): 473-481, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38385621
3.
Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspective.
J Med Econ;
27(1): 543-553, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38470512
4.
Cost-Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France.
Dermatol Ther (Heidelb);
10(6): 1331-1343, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32920709